Wall Street Breakfast cover image

Huawei preps AI chip to challenge Nvidia: report

Wall Street Breakfast

00:00

Huawei's AI Ambitions and Major Biotech Deals

This chapter explores Huawei's focus on artificial intelligence with its aim to rival NVIDIA through the Ascend 910D chip, alongside Merck KGAA's significant acquisition of SpringWorks Therapeutics to strengthen its cancer treatment capabilities. Additionally, it covers CrowdStrike's launch of new AI-driven security solutions designed to improve operations in its Securities Operations Center.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app